Di/tripeptides in cancer: from mechanisms to therapeutics

Research on tumor metabolic reprogramming has long centered on glucose, lipids and free amino acids. By contrast, di/tripeptides, which lie at the interface between protein breakdown products and functional metabolic signals, have only recently begun to be recognized as a distinct molecular tier in cancer biology. Compared with longer peptides, di/tripeptides display greater metabolic mobility and a clearer dependence on dedicated transport systems. Here we systematically review the sources, transport, metabolic use, biological functions and clinical translational potential of di/tripeptides in cancer. Current evidence indicates that di/tripeptides arise from endogenous protein degradation, dietary digestion and microbial metabolism. Under nutrient limitation, tumor cells can recover amino acids through carnosine dipeptidase 2 (CNDP2)-mediated extracellular cleavage of dipeptides or uptake of intact di/tripeptides followed by intracellular hydrolysis. Beyond their role as nutrient substrates, selected di/tripeptides directly influence tumor cell proliferation, invasion, metastasis and drug resistance, and shape the tumor microenvironment by modulating acid base balance, redox homeostasis, angiogenesis and immune cell function. At the clinical translational level, di/tripeptides have emerged as candidate metabolomic and peptidomic biomarkers, transporter targeted imaging probes, functionally modified therapeutic agents and engineered delivery modules. Di/tripeptides should be viewed as molecular nodes that connect tumor nutrient adaptation, signaling control, microenvironmental remodeling and clinical translation, with significance extending beyond their role as transient intermediates in protein metabolism.

Authors

Institutions

Publication Details

Journal
Journal of Hematology & Oncology
Published
2026-11-18
DOI
https://doi.org/10.1186/s13045-026-01873-9
Primary Topic
Biochemical effects in animals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Di/tripeptides in cancer: from mechanisms to therapeutics

Ao Du, Hongyuan Pan, Tengda Huang, Jiaxin Li et al.
Journal of Hematology & Oncology
Biochemical effects in animals
article

Di/tripeptides in cancer: from mechanisms to therapeutics

Ao Du, Hongyuan Pan, Tengda Huang, Jiaxin Li, Yan Xiang, Shiqi Ren, Mengling Wu, Kefei Yuan, Baoyun Ding, Zhixiang Zhou, Ke Qin, Xinyi Zhou
article en

Abstract

Research on tumor metabolic reprogramming has long centered on glucose, lipids and free amino acids. By contrast, di/tripeptides, which lie at the interface between protein breakdown products and functional metabolic signals, have only recently begun to be recognized as a distinct molecular tier in cancer biology. Compared with longer peptides, di/tripeptides display greater metabolic mobility and a clearer dependence on dedicated transport systems. Here we systematically review the sources, transport, metabolic use, biological functions and clinical translational potential of di/tripeptides in cancer. Current evidence indicates that di/tripeptides arise from endogenous protein degradation, dietary digestion and microbial metabolism. Under nutrient limitation, tumor cells can recover amino acids through carnosine dipeptidase 2 (CNDP2)-mediated extracellular cleavage of dipeptides or uptake of intact di/tripeptides followed by intracellular hydrolysis. Beyond their role as nutrient substrates, selected di/tripeptides directly influence tumor cell proliferation, invasion, metastasis and drug resistance, and shape the tumor microenvironment by modulating acid base balance, redox homeostasis, angiogenesis and immune cell function. At the clinical translational level, di/tripeptides have emerged as candidate metabolomic and peptidomic biomarkers, transporter targeted imaging probes, functionally modified therapeutic agents and engineered delivery modules. Di/tripeptides should be viewed as molecular nodes that connect tumor nutrient adaptation, signaling control, microenvironmental remodeling and clinical translation, with significance extending beyond their role as transient intermediates in protein metabolism.

Journal of Hematology & OncologyVol. 19(1)
Sichuan University (CN), West China Hospital of Sichuan University (CN), State Key Laboratory of Biotherapy (CN)
Biochemical effects in animals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon